THE 47TH CONGRESS OF THE ROMANIAN SOCIETY OF ANAESTHESIA
AND INTENSIVE CARE

THE 15TH ROMANIAN-FRENCH CONGRESS OF ANAESTHESIA AND INTENSIVE CARE
THE 13TH ROMANIAN-ISRAELY SYMPOSIUM ON UPDATES IN ANAESTHESIA AND INTENSIVE CARE
THE 20TH CONGRESS OF ANAESTHESIA AND INTENSIVE CARE FOR NURSES
THE 8TH SYMPOSIUM OF THE ROMANIAN AND MOLDAVIAN SOCIETIES OF ANAESTHESIA AND INTENSIVE CARE

15 - 19 SEPTEMBER 2021
Virtual Event



 

Registration Form

Starting with 04 September 2021: 

Late registration


TAKEDA PHARMACEUTICALS


City Gate, South Tower 3-5, Piața Presei Libere Street, 15th Floor, 013702 -Bucharest, 1st District, Romania
Tel.: 0040 - 37 - 247.41.75
Fax: 0040 - 21 - 335.03.04

 

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet.

Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.

Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. 

For more informatios, visit us at www.takeda.com